Research and Markets (http://www.researchandmarkets.com/research/pbvn8h/20152019_world) has announced the addition of the "2015-2019 World Cancer Diagnostics Market: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies--France, Germany, Italy, Japan, Spain, UK, US" report to their offering.

This new report is a study of the major business opportunities emerging in the global cancer diagnostics market during the next five years. The report examines trends in the U.S., Europe and Asia; reviews current and emerging assays; analyzes potential applications of new diagnostic technologies; forecasts sales of major tumor markers by country and market segment; profiles leading players and potential market entrants; and identifies specific business opportunities for suppliers.

The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the worldwide cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding field.

Anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in geriatric population will further compound the growing demand for malignancy assays and the rapid market expansion worldwide.

Scope of the Report:

Geographic Coverage:

  • France
  • Germany
  • Italy
  • Japan
  • Spain
  • UK
  • USA

Worldwide Market Overview:

  • Five-year test volume and sales projections by country.
  • Comprehensive market segmentation analysis, including review of the market dynamics, structure, size, growth and major suppliers by country.
  • Estimated universe of laboratories performing cancer diagnostic testing by country.
  • Cancer statistics, etiology and recent developments in the U.S., Europe and Asia.

Business Opportunities and Strategic Recommendations:

  • Specific new product development opportunities with potentially significant market appeal during the next five years.
  • Design criteria for new products.
  • Alternative market penetration strategies.
  • Potential market entry barriers and risks.

30 of over 50+ companies mentioned:

  • Abbott
  • AdnaGen
  • Agilent Technologies
  • Applied Gene Technologies
  • Arca BioPharma
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • Biomedical Diagnostics
  • bioMerieux
  • Bio-Rad
  • CellSearch
  • Cepheid
  • Correlogic Systems/Vermillion
  • Decode Genetics
  • Diadexus
  • Diagnocure
  • DiaSorin
  • Eiken Chemical
  • Elitech Group
  • Epigenomics
  • Enterix
  • Enzo Biochem
  • Exact Sciences
  • Fujirebio
  • Guided Therapeutics
  • Hologic/Gen-Probe
  • Kreatech/Leica
  • Kyowa Medex
  • Mackay Life Sciences
  • Myriad Genetics

For more information visit http://www.researchandmarkets.com/research/pbvn8h/20152019_world

Research and MarketsLaura Wood, Senior Managerpress@researchandmarkets.comFor E.S.T Office Hours Call 1-917-300-0470For U.S./CAN Toll Free Call 1-800-526-8630For GMT Office Hours Call +353-1-416-8900U.S. Fax: 646-607-1907Fax (outside U.S.): +353-1-481-1716Sector: Diagnostics